Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Évaluation de la Performance Diagnostique du dépistage du Cancer du Sein, Pour Une Seconde Lecture Des clichés de Mammographie assistée du Dispositif médical à Base d'Intelligence Artificielle MammoScreen

NCT05800132 is registered in ClinicalTrials.gov with Therapixel as lead sponsor.

NCT NCT05800132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05800132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Évaluation de la Performance Diagnostique du dépistage du Cancer du Sein, Pour Une Seconde Lecture Des clichés de Mammographie assistée du Dispositif médical à Base d'Intelligence Artificielle MammoScreen
Lead sponsor
Therapixel
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2023
Completion date
September 30, 2027
Enrollment
5,000 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer